Showing results (61-70 of 68) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 68 results.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 28, 2022
Early Treatment of High-Risk Hospitalized Coronavirus Disease 2019 (COVID-19) Patients With a Combination of Interferon Beta-1b and Remdesivir: A Phase 2 Open-label Randomized Controlled TrialAnthony Raymond Tam, Ricky Ruiqi Zhang, Kwok-Cheung Lung, et al.
International Journal of Biological Sciences|July 25, 2022
Phosphatidic acid phosphatase 1 impairs SARS-CoV-2 replication by affecting the glycerophospholipid metabolism pathwayBingpeng Yan, Shuofeng Yuan, Jianli Cao, et al.
Ebiomedicine|August 22, 2021
The impact of spike N501Y mutation on neutralizing activity and RBD binding of SARS-CoV-2 convalescent serumLu Lu, Allen Wing-Ho Chu, Ricky Ruiqi Zhang, et al.
The Lancet. Infectious Diseases|March 28, 2020
Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort studyKelvin Kai-Wang To, Owen Tak-Yin Tsang, Wai-Shing Leung, et al.
International Journal of Molecular Sciences|August 6, 2020
A Rapid, Simple, Inexpensive, and Mobile Colorimetric Assay COVID-19-LAMP for Mass On-Site Screening of COVID-19Franklin Wang-Ngai Chow, Tony Tat-Yin Chan, Anthony Raymond Tam, et al.
The Lancet. Infectious Diseases|June 17, 2020
SARS-CoV-2 shedding and seroconversion among passengers quarantined after disembarking a cruise ship: a case seriesIvan Fan-Ngai Hung, Vincent Chi-Chung Cheng, Xin Li, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 2, 2022
Probable Animal-to-Human Transmission of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Delta Variant AY.127 Causing a Pet Shop-Related Coronavirus Disease 2019 (COVID-19) Outbreak in Hong KongJasper Fuk Woo Chan, Gilman Kit Hang Siu, Shuofeng Yuan, et al.
Lancet (London, England)|May 14, 2020
Triple combination of interferon beta-1b, lopinavir-ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trialIvan Fan-Ngai Hung, Kwok-Cheung Lung, Eugene Yuk-Keung Tso, et al.
Pageof 7